Bellevue Life Sciences Acquisition Corp. Warrant
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp… Read more
Bellevue Life Sciences Acquisition Corp. Warrant (BLACW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.094x
Based on the latest financial reports, Bellevue Life Sciences Acquisition Corp. Warrant (BLACW) has a cash flow conversion efficiency ratio of -0.094x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.42 Million) by net assets ($15.15 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bellevue Life Sciences Acquisition Corp. Warrant - Cash Flow Conversion Efficiency Trend (2021–2023)
This chart illustrates how Bellevue Life Sciences Acquisition Corp. Warrant's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bellevue Life Sciences Acquisition Corp. Warrant Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bellevue Life Sciences Acquisition Corp. Warrant ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trail Blazer Capital Corp.
V:TBLZ-P
|
-0.027x |
|
Coro Energy PLC
LSE:CORO
|
-0.278x |
|
Verify Smart Corp
PINK:VSMR
|
0.462x |
|
GWH-WT
NYSE:GWH-WT
|
N/A |
|
JMD Properties Inc
PINK:SLDX
|
0.016x |
|
EYANG HOLDINGS
BE:4EY
|
N/A |
|
Asim Textile Mills Ltd
KAR:ASTM
|
N/A |
|
GKS GieKSa Katowice SA
WAR:GKS
|
N/A |
Annual Cash Flow Conversion Efficiency for Bellevue Life Sciences Acquisition Corp. Warrant (2021–2023)
The table below shows the annual cash flow conversion efficiency of Bellevue Life Sciences Acquisition Corp. Warrant from 2021 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $32.52 Million | $-818.77K | -0.025x | -122.30% |
| 2022-12-31 | $-37.51K | $-4.24K | 0.113x | -48.08% |
| 2021-12-31 | $-2.12K | $-461.00 | 0.217x | -- |